Cargando…
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
Colorectal cancer is a major cause of cancer-related deaths worldwide. A third of colorectal cancers reside in the rectum. Many patients with rectal cancer present in the locally-advanced stage which needs multi-modality therapy usually starting with neoadjuvant chemo-radiotherapy followed by surger...
Autores principales: | Pezeshki, Parmida Sadat, Ghalehtaki, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510210/ https://www.ncbi.nlm.nih.gov/pubmed/37726811 http://dx.doi.org/10.1186/s40364-023-00521-5 |
Ejemplares similares
-
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study
por: Wang, Yaqi, et al.
Publicado: (2021) -
Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
por: Morais, Marina, et al.
Publicado: (2023) -
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Travaini, Laura L, et al.
Publicado: (2016) -
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018) -
HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
por: Cabel, L., et al.
Publicado: (2021)